Insider Trading History of Fletcher Robert C.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Fletcher Robert C. since 2012. The trader's CIK number is 1508231. At the time of the last reporting, Fletcher Robert C. was the V.P., Business Development of Idera Pharmaceuticals, Inc.. (stock ticker symbol IDRA). Also see all insider trading activities at Idera Pharmaceuticals, Inc..

Note that in the past Fletcher Robert C. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Idera Pharmaceuticals, Inc. (IDRA) by Fletcher Robert C.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 IDRA 0 $0 1,615 $2,874 0 $0

Yearly summary of insider trading at Viropharma Inc (VPHM) by Fletcher Robert C.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 VPHM 0 $0 0 $0 88,972 $1,077,895
2012 VPHM 0 $0 32,000 $948,960 33,300 $131,966


Insider trading activities at 2 companies by Fletcher Robert C.:

1. Idera Pharmaceuticals, Inc. (IDRA)

2. Viropharma Inc (VPHM)

Table 1. Insider trading of Idera Pharmaceuticals, Inc. (IDRA) by Fletcher Robert C.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-01-07 IDRA Sale 1,615 1.78 2,874

Table 2. Insider trading of Viropharma Inc (VPHM) by Fletcher Robert C.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-12-18 VPHM Option Ex 88,972 12.12 1,077,895
2012-03-09 VPHM Sale 32,000 29.66 948,960
2012-03-09 VPHM Option Ex 32,000 3.19 102,080
2011-12-29 VPHM Option Ex 1,300 22.99 29,886

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fletcher Robert C. (V.P., Business Development of Idera Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.